Page last updated: 2024-10-23

bisoprolol and Brain Vascular Disorders

bisoprolol has been researched along with Brain Vascular Disorders in 3 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Research Excerpts

ExcerptRelevanceReference
"Clinical guidelines suggest that for patients with heart failure and concurrent chronic obstructive pulmonary disease (COPD), metoprolol/bisoprolol/nebivolol should be preferred over carvedilol."3.91Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study. ( Andersen, M; Capuano, A; Jensen, MT; Kragholm, K; Mascolo, A; Pagliaro, C; Rafaniello, C; Rasmussen, DB; Rossi, F; Sessa, M; Sportiello, L; Tari, GM, 2019)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sessa, M1
Mascolo, A1
Rasmussen, DB1
Kragholm, K1
Jensen, MT1
Sportiello, L1
Rafaniello, C1
Tari, GM1
Pagliaro, C1
Andersen, M1
Rossi, F1
Capuano, A1
Afanas'ev, IuI1
Storozhenko, SIu1
Grigorova, SIu1
Segev, A1
Mekori, YA1

Other Studies

3 other studies available for bisoprolol and Brain Vascular Disorders

ArticleYear
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
    Scientific reports, 2019, 08-07, Volume: 9, Issue:1

    Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrioventricular Block; Bisoprolol; Carvedilol

2019
[Potentialities of medicinal correction of cerebrovascular disturbances in patients with arterial hypertension].
    Klinicheskaia meditsina, 2012, Volume: 90, Issue:6

    Topics: Amlodipine; Antihypertensive Agents; Bisoprolol; Cerebrovascular Disorders; Drug Therapy, Combinatio

2012
The Cardiac Insufficiency Bisoprolol Study II.
    Lancet (London, England), 1999, Apr-17, Volume: 353, Issue:9161

    Topics: Adrenergic beta-Antagonists; Bisoprolol; Cerebrovascular Disorders; Humans; Thrombosis; Ventricular

1999